Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00399"

Predicate	Value (sorted: none)
drugbank:drugCategory	drugcategory:Bisphosphonates
rdfs:label	"Zoledronate"
drugbank:drugCategory	drugcategory:Bone Density Conservation Agents
drugbank:description	"Zoledronate (zoledronic acid, marketed by Novartis under the trade names Zometa and Reclast) is a bisphosphonate. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. An annual dose of Zoledronate may also prevent recurring fractures in patients with a previous hip fracture. Zoledronate is a single 5 mg infusion for the treatment of Paget's disease of bone. In 2007, the FDA also approved Reclast for the treatment of postmenopausal osteoporosis."
drugbank:drugCategory	drugcategory:Antihypocalcemic Agents
owl:sameAs	drug:Zoledronate
rdf:type	drugbank:drugs
owl:sameAs	drug:APRD01294
owl:sameAs	drug:DB06286
owl:sameAs	drug:Cholesterol
owl:sameAs	drug:Iron
owl:sameAs	drug:Geranyl Diphosphate
owl:sameAs	drug:Cholecalciferol
drugbank:drugCategory	drugcategory:Antiresorptives

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource appears as object in 5 triples

Context graph